Talkspace Inc Revenue Growth Rates (TALK), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Talkspace Inc   (NASDAQ: TALK)
 

TALK's Revenue Growth by Quarter and Year

Talkspace Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TALK Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 61.67
1st Quarter March 61.68
FY 123.35

TALKs Annual Revenue
Talkspace Inc 's Revenue in the fiscal year 2025 $ 228.87 millions
Talkspace Inc 's Revenue in the fiscal year 2024 $ 186.84 millions
Talkspace Inc 's Revenue in the fiscal year 2023 $ 149.38 millions
Talkspace Inc 's Revenue in the fiscal year 2022 $ 119.57 millions
Talkspace Inc 's Revenue in the fiscal year 2021 $ 113.67 millions




TALK Revenue second quarter 2026 Y/Y Growth Comment
Talkspace Inc reported Revenue increase of 13.56% year on year in the second quarter 2026, to $ 61.67 millions, this is lower than Talkspace Inc 's recent average Revenue surge of 151.4%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 77 other companies have achieved higher Revenue growth. While Talkspace Inc ' s Revenue growth of 13.56% ranks overall at the positon no. 1405 in the second quarter 2026.


TALK Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 29.01 % 16.4 % 40.71 %
3rd Quarter September - 27.37 % 23.17 % 29.05 %
2nd Quarter June 13.56 % 18.19 % 28.89 % 19.47 %
1st Quarter March 20.28 % 14.64 % 34.16 % 10.58 %
FY   - 22.5 % 25.06 % -

Financial Statements
Talkspace Inc 's second quarter 2026 Revenue $ 61.67 millions TALK's Income Statement
Talkspace Inc 's second quarter 2025 Revenue $ 54.31 millions Quarterly TALK's Income Statement


TALK Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 7.61 % 6.24 % 12.42 %
3rd Quarter September - 9.34 % 1.46 % 6.17 %
2nd Quarter June -0.01 % 5.91 % 2.73 % 6.93 %
1st Quarter March -3.47 % 3.53 % 5.12 % 10.25 %
FY (Year on Year)   - 22.5 % 25.06 % -


Back to TALK Growth rate Comparisons >> Back to TALK Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #78
Healthcare Sector #245
Overall #1405

Revenue Y/Y Growth Statistics
High Average Low
3713.74 % 151.4 % -44.39 %
(Jun 30 2021)   (Nov 30 2015)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #78
Healthcare Sector #245
Overall #1405
Revenue Y/Y Growth Statistics
High Average Low
3713.74 % 151.4 % -44.39 %
(Jun 30 2021)   (Nov 30 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Talkspace Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3215.02 % 96.79 % -100 %
(Aug 31 2013)  


TALK's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Talkspace Inc disclosed decrease in Revenue from the first quarter by -0.01% to $ 61.67 millions, from $ 61.68 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 73 other companies have achieved higher Revenue quarter on quarter growth. While Talkspace Inc 's Revenue growth quarter on quarter, overall rank is 1779.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #74
Healthcare Sector #237
Overall #1779
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #74
Healthcare Sector #237
Overall #1779
Revenue Q/Q Growth Statistics
High Average Low
3215.02 % 96.79 % -100 %
(Aug 31 2013)  


TALK's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Talkspace Inc disclosed decrease in Revenue from the first quarter by -0.01% to $ 61.67 millions, from $ 61.68 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 73 other companies have achieved higher Revenue quarter on quarter growth. While Talkspace Inc 's Revenue growth quarter on quarter, overall rank is 1779.


Talkspace Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 246.63 $ 239.27 $ 228.87 $ 214.51 $ 201.75
Y / Y Revenue Growth (TTM) 22.25 % 23.73 % 22.5 % 19.27 % 17.92 %
Year on Year Revenue Growth Overall Ranking # 940 # 668 # 392 # 235 # 317
Seqeuential Revenue Change (TTM) 3.08 % 4.54 % 6.7 % 6.32 % 4.32 %
Seq. Revenue Growth (TTM) Overall Ranking # 2126 # 1886 # 1610 # 1170 # 1370


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Talkspace Inc 's cumulative twelve months Revenue were $ 247 millions, company would post below average annual Revenue growth of 4.32% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Talkspace Inc 's Revenue growth from the 61.68% growth in Mar 31 2026.

In the Healthcare sector 183 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 668 to 940.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 184
Overall # 940

Revenue TTM Y/Y Growth Statistics
High Average Low
4082.93 %
 215.84 %
-16.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 321
S&P 500 # 2126
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Talkspace Inc 's cumulative twelve months Revenue were $ 247 millions, company would post below average annual Revenue growth of -16.46% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Talkspace Inc 's Revenue growth from the 61.68% growth in Mar 31 2026.

In the Healthcare sector 183 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 668 to 940.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 184
Overall # 940

Revenue TTM Y/Y Growth Statistics
High Average Low
4082.93 %
215.84 %
-16.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 321
S&P 500 # 2126




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TALK's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Insulet Corporation23.51%$ 23.509 millions
Veracyte Inc 23.45%$ 23.448 millions
Journey Medical Corp23.33%$ 23.326 millions
Twist Bioscience Corporation23.24%$ 23.235 millions
Axogen inc 23.06%$ 23.065 millions
Vericel Corporation22.48%$ 22.481 millions
Milestone Scientific Inc 22.28%$ 22.276 millions
Alpha Teknova Inc 22.05%$ 22.045 millions
X4 Pharmaceuticals Inc21.64%$ 21.642 millions
Exagen Inc 21.63%$ 21.629 millions
Adaptive Biotechnologies Corporation21.53%$ 21.526 millions
Privia Health Group Inc 21.39%$ 21.390 millions
Bionano Genomics Inc 21.36%$ 21.357 millions
Evolus Inc 21.30%$ 21.298 millions
Invivyd Inc 21.20%$ 21.203 millions
Transmedics Group Inc 20.70%$ 20.702 millions
Irhythm Holdings Inc 20.62%$ 20.615 millions
Delcath Systems Inc 20.60%$ 20.604 millions
Castle Biosciences Inc 20.14%$ 20.140 millions
Procept Biorobotics Corporation20.00%$ 20.004 millions
Biomarin Pharmaceutical Inc19.91%$ 19.905 millions
Cannapharmarx Inc 19.26%$ 19.261 millions
Anika Therapeutics Inc 19.18%$ 19.176 millions
Bioaffinity Technologies Inc 18.99%$ 18.992 millions
Aurinia Pharmaceuticals Inc 18.87%$ 18.872 millions
Camp4 Therapeutics Corporation18.84%$ 18.838 millions
Lensar Inc 18.37%$ 18.371 millions
Immunocore Holdings Plc18.34%$ 18.336 millions
Innovage Holding Corp 18.31%$ 18.307 millions
Koru Medical Systems Inc 18.15%$ 18.153 millions


About Talkspace Inc Revenue Growth Rates (TALK), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.